Condition: Influenza, Human · Sponsor: Yiling Pharmaceutical Inc.
The purpose of this study is to investigate clinical efficacy of KT07 capsule in alleviation of fever and other symptoms including nasal congestion, sore throat, cough, aches and pains, fatigue, headache, chills or sweats in subjects with acute uncomplicated influenza.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Central Alabama Research | Birmingham, Alabama, United States | — |
| Parkway Medical Center, LLC | Birmingham, Alabama, United States | — |
| Cahaba Research, Inc. | Birmingham, Alabama, United States | — |
| David Wever | Pelham, Alabama, United States | — |
| Alliane Urgent Care | Tolleson, Arizona, United States | — |
| Orange County Research Institute | Anaheim, California, United States | — |
| Hope Clinical Research, Inc. | Canoga Park, California, United States | — |
| Core Health Care Group | Cerritos, California, United States | — |
| Aviva Research | Escondido, California, United States | — |
| Lalla-Reddy Medical Corp. | Fountain Valley, California, United States | — |
| Research Center of Fresno, Inc. | Fresno, California, United States | — |
| Ark Clinical Research | Long Beach, California, United States | — |
+ 69 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02867358